Global Medical Aesthetic Drugs Supply, Demand and Key Producers, 2023-2029
The global Medical Aesthetic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Part of Medical Aesthetic Drugs includes medications and skin care products that are used to improve skin quality, reduce skin imperfections and lighten discolouration. These products may include ingredients such as vitamin C, hyaluronic acid, squalene, and various antioxidants. Botulinum toxin (Botox) and fillers (such as hyaluronic acid) are widely used to reduce wrinkles, improve facial lines, and increase youthfulness of appearance. These treatments are usually injected by a physician. Different types of laser treatments are used to remove redness, reduce pigmentation, remove skin blemishes and reduce wrinkles. Techniques and equipment for laser treatments continue to advance to provide more effective and safe results. A number of medications and compounds have been developed to treat skin problems such as acne, pigmentation and skin laxity. These medications may require a prescription and are administered under the supervision of a physician or dermatologist. Due to the growing field of medical and aesthetic medications, it has become even more important to conduct clinical studies and regulate the safety and efficacy of products. Government and regulatory agencies have established regulations to ensure the safety and compliance of medicinal aesthetic drugs.
Medical Aesthetic Drugs refer to pharmaceutical products and medications that are specifically used in the field of Medical Aesthetic Drugs. These drugs are designed to enhance or restore an individual's appearance by addressing various cosmetic concerns, such as wrinkles, fine lines, volume loss, skin texture, and pigmentation irregularities.
This report studies the global Medical Aesthetic Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Aesthetic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Aesthetic Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Aesthetic Drugs total market, 2018-2029, (USD Million)
Global Medical Aesthetic Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Medical Aesthetic Drugs total market, key domestic companies and share, (USD Million)
Global Medical Aesthetic Drugs revenue by player and market share 2018-2023, (USD Million)
Global Medical Aesthetic Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Medical Aesthetic Drugs total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Medical Aesthetic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Galderma, LG Life Science, Merz Aesthetics, Ipsen, Syneron Medical, Cynosure, Mentor Worldwide and Medytox, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Aesthetic Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Medical Aesthetic Drugs Market, By Region:
1. How big is the global Medical Aesthetic Drugs market?
2. What is the demand of the global Medical Aesthetic Drugs market?
3. What is the year over year growth of the global Medical Aesthetic Drugs market?
4. What is the total value of the global Medical Aesthetic Drugs market?
5. Who are the major players in the global Medical Aesthetic Drugs market?
Part of Medical Aesthetic Drugs includes medications and skin care products that are used to improve skin quality, reduce skin imperfections and lighten discolouration. These products may include ingredients such as vitamin C, hyaluronic acid, squalene, and various antioxidants. Botulinum toxin (Botox) and fillers (such as hyaluronic acid) are widely used to reduce wrinkles, improve facial lines, and increase youthfulness of appearance. These treatments are usually injected by a physician. Different types of laser treatments are used to remove redness, reduce pigmentation, remove skin blemishes and reduce wrinkles. Techniques and equipment for laser treatments continue to advance to provide more effective and safe results. A number of medications and compounds have been developed to treat skin problems such as acne, pigmentation and skin laxity. These medications may require a prescription and are administered under the supervision of a physician or dermatologist. Due to the growing field of medical and aesthetic medications, it has become even more important to conduct clinical studies and regulate the safety and efficacy of products. Government and regulatory agencies have established regulations to ensure the safety and compliance of medicinal aesthetic drugs.
Medical Aesthetic Drugs refer to pharmaceutical products and medications that are specifically used in the field of Medical Aesthetic Drugs. These drugs are designed to enhance or restore an individual's appearance by addressing various cosmetic concerns, such as wrinkles, fine lines, volume loss, skin texture, and pigmentation irregularities.
This report studies the global Medical Aesthetic Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Aesthetic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Aesthetic Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Aesthetic Drugs total market, 2018-2029, (USD Million)
Global Medical Aesthetic Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Medical Aesthetic Drugs total market, key domestic companies and share, (USD Million)
Global Medical Aesthetic Drugs revenue by player and market share 2018-2023, (USD Million)
Global Medical Aesthetic Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Medical Aesthetic Drugs total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Medical Aesthetic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Galderma, LG Life Science, Merz Aesthetics, Ipsen, Syneron Medical, Cynosure, Mentor Worldwide and Medytox, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Aesthetic Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Medical Aesthetic Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Dermal Fillers
- Botulinum Toxin
- Breast Implants
- Others
- Facial Injectable
- Fat Reduction
- Breast Implant
- Others
- Allergan
- Galderma
- LG Life Science
- Merz Aesthetics
- Ipsen
- Syneron Medical
- Cynosure
- Mentor Worldwide
- Medytox
- Valeant Pharmaceuticals
- Fosun Pharma
- Teoxane
- Bloomage
- GC Aesthetics
- Suneva Medical
- Revance Therapeutics
- Sinclair Pharma
- Prollenium
- Lumenis
- Hologic
- Bloomage Biotechnology Corporation Limited
- Shanghai Shyndec Pharmaceutical Co., Ltd.
- Lancy Co., Ltd.
- Aoyuan Beauty Valley Technology Co., Ltd.
- Huadong MEDICINE Co., Ltd.
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Lushang Freda Pharmaceutical Co., Ltd.
- Guangdong Marubi Biotechnology Co., Ltd.
- Shenzhen Lifotronic Technology Co., Ltd.
1. How big is the global Medical Aesthetic Drugs market?
2. What is the demand of the global Medical Aesthetic Drugs market?
3. What is the year over year growth of the global Medical Aesthetic Drugs market?
4. What is the total value of the global Medical Aesthetic Drugs market?
5. Who are the major players in the global Medical Aesthetic Drugs market?
1 SUPPLY SUMMARY
1.1 Medical Aesthetic Drugs Introduction
1.2 World Medical Aesthetic Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Medical Aesthetic Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Medical Aesthetic Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Medical Aesthetic Drugs Market Size (2018-2029)
1.3.3 China Medical Aesthetic Drugs Market Size (2018-2029)
1.3.4 Europe Medical Aesthetic Drugs Market Size (2018-2029)
1.3.5 Japan Medical Aesthetic Drugs Market Size (2018-2029)
1.3.6 South Korea Medical Aesthetic Drugs Market Size (2018-2029)
1.3.7 ASEAN Medical Aesthetic Drugs Market Size (2018-2029)
1.3.8 India Medical Aesthetic Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Aesthetic Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medical Aesthetic Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Medical Aesthetic Drugs Consumption Value (2018-2029)
2.2 World Medical Aesthetic Drugs Consumption Value by Region
2.2.1 World Medical Aesthetic Drugs Consumption Value by Region (2018-2023)
2.2.2 World Medical Aesthetic Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Medical Aesthetic Drugs Consumption Value (2018-2029)
2.4 China Medical Aesthetic Drugs Consumption Value (2018-2029)
2.5 Europe Medical Aesthetic Drugs Consumption Value (2018-2029)
2.6 Japan Medical Aesthetic Drugs Consumption Value (2018-2029)
2.7 South Korea Medical Aesthetic Drugs Consumption Value (2018-2029)
2.8 ASEAN Medical Aesthetic Drugs Consumption Value (2018-2029)
2.9 India Medical Aesthetic Drugs Consumption Value (2018-2029)
3 WORLD MEDICAL AESTHETIC DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Medical Aesthetic Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Medical Aesthetic Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Medical Aesthetic Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Medical Aesthetic Drugs in 2022
3.3 Medical Aesthetic Drugs Company Evaluation Quadrant
3.4 Medical Aesthetic Drugs Market: Overall Company Footprint Analysis
3.4.1 Medical Aesthetic Drugs Market: Region Footprint
3.4.2 Medical Aesthetic Drugs Market: Company Product Type Footprint
3.4.3 Medical Aesthetic Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Medical Aesthetic Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Medical Aesthetic Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Medical Aesthetic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Medical Aesthetic Drugs Consumption Value Comparison
4.2.1 United States VS China: Medical Aesthetic Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medical Aesthetic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Medical Aesthetic Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Medical Aesthetic Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Medical Aesthetic Drugs Revenue, (2018-2023)
4.4 China Based Companies Medical Aesthetic Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Medical Aesthetic Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Medical Aesthetic Drugs Revenue, (2018-2023)
4.5 Rest of World Based Medical Aesthetic Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Medical Aesthetic Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Medical Aesthetic Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Medical Aesthetic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Dermal Fillers
5.2.2 Botulinum Toxin
5.2.3 Breast Implants
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Medical Aesthetic Drugs Market Size by Type (2018-2023)
5.3.2 World Medical Aesthetic Drugs Market Size by Type (2024-2029)
5.3.3 World Medical Aesthetic Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Medical Aesthetic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Facial Injectable
6.2.2 Fat Reduction
6.2.3 Breast Implant
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Medical Aesthetic Drugs Market Size by Application (2018-2023)
6.3.2 World Medical Aesthetic Drugs Market Size by Application (2024-2029)
6.3.3 World Medical Aesthetic Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Allergan
7.1.1 Allergan Details
7.1.2 Allergan Major Business
7.1.3 Allergan Medical Aesthetic Drugs Product and Services
7.1.4 Allergan Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Allergan Recent Developments/Updates
7.1.6 Allergan Competitive Strengths & Weaknesses
7.2 Galderma
7.2.1 Galderma Details
7.2.2 Galderma Major Business
7.2.3 Galderma Medical Aesthetic Drugs Product and Services
7.2.4 Galderma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Galderma Recent Developments/Updates
7.2.6 Galderma Competitive Strengths & Weaknesses
7.3 LG Life Science
7.3.1 LG Life Science Details
7.3.2 LG Life Science Major Business
7.3.3 LG Life Science Medical Aesthetic Drugs Product and Services
7.3.4 LG Life Science Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 LG Life Science Recent Developments/Updates
7.3.6 LG Life Science Competitive Strengths & Weaknesses
7.4 Merz Aesthetics
7.4.1 Merz Aesthetics Details
7.4.2 Merz Aesthetics Major Business
7.4.3 Merz Aesthetics Medical Aesthetic Drugs Product and Services
7.4.4 Merz Aesthetics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Merz Aesthetics Recent Developments/Updates
7.4.6 Merz Aesthetics Competitive Strengths & Weaknesses
7.5 Ipsen
7.5.1 Ipsen Details
7.5.2 Ipsen Major Business
7.5.3 Ipsen Medical Aesthetic Drugs Product and Services
7.5.4 Ipsen Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Ipsen Recent Developments/Updates
7.5.6 Ipsen Competitive Strengths & Weaknesses
7.6 Syneron Medical
7.6.1 Syneron Medical Details
7.6.2 Syneron Medical Major Business
7.6.3 Syneron Medical Medical Aesthetic Drugs Product and Services
7.6.4 Syneron Medical Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Syneron Medical Recent Developments/Updates
7.6.6 Syneron Medical Competitive Strengths & Weaknesses
7.7 Cynosure
7.7.1 Cynosure Details
7.7.2 Cynosure Major Business
7.7.3 Cynosure Medical Aesthetic Drugs Product and Services
7.7.4 Cynosure Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Cynosure Recent Developments/Updates
7.7.6 Cynosure Competitive Strengths & Weaknesses
7.8 Mentor Worldwide
7.8.1 Mentor Worldwide Details
7.8.2 Mentor Worldwide Major Business
7.8.3 Mentor Worldwide Medical Aesthetic Drugs Product and Services
7.8.4 Mentor Worldwide Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Mentor Worldwide Recent Developments/Updates
7.8.6 Mentor Worldwide Competitive Strengths & Weaknesses
7.9 Medytox
7.9.1 Medytox Details
7.9.2 Medytox Major Business
7.9.3 Medytox Medical Aesthetic Drugs Product and Services
7.9.4 Medytox Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Medytox Recent Developments/Updates
7.9.6 Medytox Competitive Strengths & Weaknesses
7.10 Valeant Pharmaceuticals
7.10.1 Valeant Pharmaceuticals Details
7.10.2 Valeant Pharmaceuticals Major Business
7.10.3 Valeant Pharmaceuticals Medical Aesthetic Drugs Product and Services
7.10.4 Valeant Pharmaceuticals Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Valeant Pharmaceuticals Recent Developments/Updates
7.10.6 Valeant Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Fosun Pharma
7.11.1 Fosun Pharma Details
7.11.2 Fosun Pharma Major Business
7.11.3 Fosun Pharma Medical Aesthetic Drugs Product and Services
7.11.4 Fosun Pharma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Fosun Pharma Recent Developments/Updates
7.11.6 Fosun Pharma Competitive Strengths & Weaknesses
7.12 Teoxane
7.12.1 Teoxane Details
7.12.2 Teoxane Major Business
7.12.3 Teoxane Medical Aesthetic Drugs Product and Services
7.12.4 Teoxane Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Teoxane Recent Developments/Updates
7.12.6 Teoxane Competitive Strengths & Weaknesses
7.13 Bloomage
7.13.1 Bloomage Details
7.13.2 Bloomage Major Business
7.13.3 Bloomage Medical Aesthetic Drugs Product and Services
7.13.4 Bloomage Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Bloomage Recent Developments/Updates
7.13.6 Bloomage Competitive Strengths & Weaknesses
7.14 GC Aesthetics
7.14.1 GC Aesthetics Details
7.14.2 GC Aesthetics Major Business
7.14.3 GC Aesthetics Medical Aesthetic Drugs Product and Services
7.14.4 GC Aesthetics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 GC Aesthetics Recent Developments/Updates
7.14.6 GC Aesthetics Competitive Strengths & Weaknesses
7.15 Suneva Medical
7.15.1 Suneva Medical Details
7.15.2 Suneva Medical Major Business
7.15.3 Suneva Medical Medical Aesthetic Drugs Product and Services
7.15.4 Suneva Medical Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Suneva Medical Recent Developments/Updates
7.15.6 Suneva Medical Competitive Strengths & Weaknesses
7.16 Revance Therapeutics
7.16.1 Revance Therapeutics Details
7.16.2 Revance Therapeutics Major Business
7.16.3 Revance Therapeutics Medical Aesthetic Drugs Product and Services
7.16.4 Revance Therapeutics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Revance Therapeutics Recent Developments/Updates
7.16.6 Revance Therapeutics Competitive Strengths & Weaknesses
7.17 Sinclair Pharma
7.17.1 Sinclair Pharma Details
7.17.2 Sinclair Pharma Major Business
7.17.3 Sinclair Pharma Medical Aesthetic Drugs Product and Services
7.17.4 Sinclair Pharma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Sinclair Pharma Recent Developments/Updates
7.17.6 Sinclair Pharma Competitive Strengths & Weaknesses
7.18 Prollenium
7.18.1 Prollenium Details
7.18.2 Prollenium Major Business
7.18.3 Prollenium Medical Aesthetic Drugs Product and Services
7.18.4 Prollenium Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Prollenium Recent Developments/Updates
7.18.6 Prollenium Competitive Strengths & Weaknesses
7.19 Lumenis
7.19.1 Lumenis Details
7.19.2 Lumenis Major Business
7.19.3 Lumenis Medical Aesthetic Drugs Product and Services
7.19.4 Lumenis Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Lumenis Recent Developments/Updates
7.19.6 Lumenis Competitive Strengths & Weaknesses
7.20 Hologic
7.20.1 Hologic Details
7.20.2 Hologic Major Business
7.20.3 Hologic Medical Aesthetic Drugs Product and Services
7.20.4 Hologic Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Hologic Recent Developments/Updates
7.20.6 Hologic Competitive Strengths & Weaknesses
7.21 Bloomage Biotechnology Corporation Limited
7.21.1 Bloomage Biotechnology Corporation Limited Details
7.21.2 Bloomage Biotechnology Corporation Limited Major Business
7.21.3 Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Product and Services
7.21.4 Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Bloomage Biotechnology Corporation Limited Recent Developments/Updates
7.21.6 Bloomage Biotechnology Corporation Limited Competitive Strengths & Weaknesses
7.22 Shanghai Shyndec Pharmaceutical Co., Ltd.
7.22.1 Shanghai Shyndec Pharmaceutical Co., Ltd. Details
7.22.2 Shanghai Shyndec Pharmaceutical Co., Ltd. Major Business
7.22.3 Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Product and Services
7.22.4 Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Shanghai Shyndec Pharmaceutical Co., Ltd. Recent Developments/Updates
7.22.6 Shanghai Shyndec Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.23 Lancy Co., Ltd.
7.23.1 Lancy Co., Ltd. Details
7.23.2 Lancy Co., Ltd. Major Business
7.23.3 Lancy Co., Ltd. Medical Aesthetic Drugs Product and Services
7.23.4 Lancy Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Lancy Co., Ltd. Recent Developments/Updates
7.23.6 Lancy Co., Ltd. Competitive Strengths & Weaknesses
7.24 Aoyuan Beauty Valley Technology Co., Ltd.
7.24.1 Aoyuan Beauty Valley Technology Co., Ltd. Details
7.24.2 Aoyuan Beauty Valley Technology Co., Ltd. Major Business
7.24.3 Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Product and Services
7.24.4 Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Aoyuan Beauty Valley Technology Co., Ltd. Recent Developments/Updates
7.24.6 Aoyuan Beauty Valley Technology Co., Ltd. Competitive Strengths & Weaknesses
7.25 Huadong MEDICINE Co., Ltd.
7.25.1 Huadong MEDICINE Co., Ltd. Details
7.25.2 Huadong MEDICINE Co., Ltd. Major Business
7.25.3 Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Product and Services
7.25.4 Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Huadong MEDICINE Co., Ltd. Recent Developments/Updates
7.25.6 Huadong MEDICINE Co., Ltd. Competitive Strengths & Weaknesses
7.26 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
7.26.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Details
7.26.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Major Business
7.26.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Product and Services
7.26.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
7.26.6 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Competitive Strengths & Weaknesses
7.27 Lushang Freda Pharmaceutical Co., Ltd.
7.27.1 Lushang Freda Pharmaceutical Co., Ltd. Details
7.27.2 Lushang Freda Pharmaceutical Co., Ltd. Major Business
7.27.3 Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Product and Services
7.27.4 Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 Lushang Freda Pharmaceutical Co., Ltd. Recent Developments/Updates
7.27.6 Lushang Freda Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.28 Guangdong Marubi Biotechnology Co., Ltd.
7.28.1 Guangdong Marubi Biotechnology Co., Ltd. Details
7.28.2 Guangdong Marubi Biotechnology Co., Ltd. Major Business
7.28.3 Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Product and Services
7.28.4 Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 Guangdong Marubi Biotechnology Co., Ltd. Recent Developments/Updates
7.28.6 Guangdong Marubi Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.29 Shenzhen Lifotronic Technology Co., Ltd.
7.29.1 Shenzhen Lifotronic Technology Co., Ltd. Details
7.29.2 Shenzhen Lifotronic Technology Co., Ltd. Major Business
7.29.3 Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Product and Services
7.29.4 Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 Shenzhen Lifotronic Technology Co., Ltd. Recent Developments/Updates
7.29.6 Shenzhen Lifotronic Technology Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Medical Aesthetic Drugs Industry Chain
8.2 Medical Aesthetic Drugs Upstream Analysis
8.3 Medical Aesthetic Drugs Midstream Analysis
8.4 Medical Aesthetic Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Medical Aesthetic Drugs Introduction
1.2 World Medical Aesthetic Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Medical Aesthetic Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Medical Aesthetic Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Medical Aesthetic Drugs Market Size (2018-2029)
1.3.3 China Medical Aesthetic Drugs Market Size (2018-2029)
1.3.4 Europe Medical Aesthetic Drugs Market Size (2018-2029)
1.3.5 Japan Medical Aesthetic Drugs Market Size (2018-2029)
1.3.6 South Korea Medical Aesthetic Drugs Market Size (2018-2029)
1.3.7 ASEAN Medical Aesthetic Drugs Market Size (2018-2029)
1.3.8 India Medical Aesthetic Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Aesthetic Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medical Aesthetic Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Medical Aesthetic Drugs Consumption Value (2018-2029)
2.2 World Medical Aesthetic Drugs Consumption Value by Region
2.2.1 World Medical Aesthetic Drugs Consumption Value by Region (2018-2023)
2.2.2 World Medical Aesthetic Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Medical Aesthetic Drugs Consumption Value (2018-2029)
2.4 China Medical Aesthetic Drugs Consumption Value (2018-2029)
2.5 Europe Medical Aesthetic Drugs Consumption Value (2018-2029)
2.6 Japan Medical Aesthetic Drugs Consumption Value (2018-2029)
2.7 South Korea Medical Aesthetic Drugs Consumption Value (2018-2029)
2.8 ASEAN Medical Aesthetic Drugs Consumption Value (2018-2029)
2.9 India Medical Aesthetic Drugs Consumption Value (2018-2029)
3 WORLD MEDICAL AESTHETIC DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Medical Aesthetic Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Medical Aesthetic Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Medical Aesthetic Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Medical Aesthetic Drugs in 2022
3.3 Medical Aesthetic Drugs Company Evaluation Quadrant
3.4 Medical Aesthetic Drugs Market: Overall Company Footprint Analysis
3.4.1 Medical Aesthetic Drugs Market: Region Footprint
3.4.2 Medical Aesthetic Drugs Market: Company Product Type Footprint
3.4.3 Medical Aesthetic Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Medical Aesthetic Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Medical Aesthetic Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Medical Aesthetic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Medical Aesthetic Drugs Consumption Value Comparison
4.2.1 United States VS China: Medical Aesthetic Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medical Aesthetic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Medical Aesthetic Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Medical Aesthetic Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Medical Aesthetic Drugs Revenue, (2018-2023)
4.4 China Based Companies Medical Aesthetic Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Medical Aesthetic Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Medical Aesthetic Drugs Revenue, (2018-2023)
4.5 Rest of World Based Medical Aesthetic Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Medical Aesthetic Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Medical Aesthetic Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Medical Aesthetic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Dermal Fillers
5.2.2 Botulinum Toxin
5.2.3 Breast Implants
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Medical Aesthetic Drugs Market Size by Type (2018-2023)
5.3.2 World Medical Aesthetic Drugs Market Size by Type (2024-2029)
5.3.3 World Medical Aesthetic Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Medical Aesthetic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Facial Injectable
6.2.2 Fat Reduction
6.2.3 Breast Implant
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Medical Aesthetic Drugs Market Size by Application (2018-2023)
6.3.2 World Medical Aesthetic Drugs Market Size by Application (2024-2029)
6.3.3 World Medical Aesthetic Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Allergan
7.1.1 Allergan Details
7.1.2 Allergan Major Business
7.1.3 Allergan Medical Aesthetic Drugs Product and Services
7.1.4 Allergan Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Allergan Recent Developments/Updates
7.1.6 Allergan Competitive Strengths & Weaknesses
7.2 Galderma
7.2.1 Galderma Details
7.2.2 Galderma Major Business
7.2.3 Galderma Medical Aesthetic Drugs Product and Services
7.2.4 Galderma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Galderma Recent Developments/Updates
7.2.6 Galderma Competitive Strengths & Weaknesses
7.3 LG Life Science
7.3.1 LG Life Science Details
7.3.2 LG Life Science Major Business
7.3.3 LG Life Science Medical Aesthetic Drugs Product and Services
7.3.4 LG Life Science Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 LG Life Science Recent Developments/Updates
7.3.6 LG Life Science Competitive Strengths & Weaknesses
7.4 Merz Aesthetics
7.4.1 Merz Aesthetics Details
7.4.2 Merz Aesthetics Major Business
7.4.3 Merz Aesthetics Medical Aesthetic Drugs Product and Services
7.4.4 Merz Aesthetics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Merz Aesthetics Recent Developments/Updates
7.4.6 Merz Aesthetics Competitive Strengths & Weaknesses
7.5 Ipsen
7.5.1 Ipsen Details
7.5.2 Ipsen Major Business
7.5.3 Ipsen Medical Aesthetic Drugs Product and Services
7.5.4 Ipsen Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Ipsen Recent Developments/Updates
7.5.6 Ipsen Competitive Strengths & Weaknesses
7.6 Syneron Medical
7.6.1 Syneron Medical Details
7.6.2 Syneron Medical Major Business
7.6.3 Syneron Medical Medical Aesthetic Drugs Product and Services
7.6.4 Syneron Medical Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Syneron Medical Recent Developments/Updates
7.6.6 Syneron Medical Competitive Strengths & Weaknesses
7.7 Cynosure
7.7.1 Cynosure Details
7.7.2 Cynosure Major Business
7.7.3 Cynosure Medical Aesthetic Drugs Product and Services
7.7.4 Cynosure Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Cynosure Recent Developments/Updates
7.7.6 Cynosure Competitive Strengths & Weaknesses
7.8 Mentor Worldwide
7.8.1 Mentor Worldwide Details
7.8.2 Mentor Worldwide Major Business
7.8.3 Mentor Worldwide Medical Aesthetic Drugs Product and Services
7.8.4 Mentor Worldwide Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Mentor Worldwide Recent Developments/Updates
7.8.6 Mentor Worldwide Competitive Strengths & Weaknesses
7.9 Medytox
7.9.1 Medytox Details
7.9.2 Medytox Major Business
7.9.3 Medytox Medical Aesthetic Drugs Product and Services
7.9.4 Medytox Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Medytox Recent Developments/Updates
7.9.6 Medytox Competitive Strengths & Weaknesses
7.10 Valeant Pharmaceuticals
7.10.1 Valeant Pharmaceuticals Details
7.10.2 Valeant Pharmaceuticals Major Business
7.10.3 Valeant Pharmaceuticals Medical Aesthetic Drugs Product and Services
7.10.4 Valeant Pharmaceuticals Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Valeant Pharmaceuticals Recent Developments/Updates
7.10.6 Valeant Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Fosun Pharma
7.11.1 Fosun Pharma Details
7.11.2 Fosun Pharma Major Business
7.11.3 Fosun Pharma Medical Aesthetic Drugs Product and Services
7.11.4 Fosun Pharma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Fosun Pharma Recent Developments/Updates
7.11.6 Fosun Pharma Competitive Strengths & Weaknesses
7.12 Teoxane
7.12.1 Teoxane Details
7.12.2 Teoxane Major Business
7.12.3 Teoxane Medical Aesthetic Drugs Product and Services
7.12.4 Teoxane Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Teoxane Recent Developments/Updates
7.12.6 Teoxane Competitive Strengths & Weaknesses
7.13 Bloomage
7.13.1 Bloomage Details
7.13.2 Bloomage Major Business
7.13.3 Bloomage Medical Aesthetic Drugs Product and Services
7.13.4 Bloomage Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Bloomage Recent Developments/Updates
7.13.6 Bloomage Competitive Strengths & Weaknesses
7.14 GC Aesthetics
7.14.1 GC Aesthetics Details
7.14.2 GC Aesthetics Major Business
7.14.3 GC Aesthetics Medical Aesthetic Drugs Product and Services
7.14.4 GC Aesthetics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 GC Aesthetics Recent Developments/Updates
7.14.6 GC Aesthetics Competitive Strengths & Weaknesses
7.15 Suneva Medical
7.15.1 Suneva Medical Details
7.15.2 Suneva Medical Major Business
7.15.3 Suneva Medical Medical Aesthetic Drugs Product and Services
7.15.4 Suneva Medical Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Suneva Medical Recent Developments/Updates
7.15.6 Suneva Medical Competitive Strengths & Weaknesses
7.16 Revance Therapeutics
7.16.1 Revance Therapeutics Details
7.16.2 Revance Therapeutics Major Business
7.16.3 Revance Therapeutics Medical Aesthetic Drugs Product and Services
7.16.4 Revance Therapeutics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Revance Therapeutics Recent Developments/Updates
7.16.6 Revance Therapeutics Competitive Strengths & Weaknesses
7.17 Sinclair Pharma
7.17.1 Sinclair Pharma Details
7.17.2 Sinclair Pharma Major Business
7.17.3 Sinclair Pharma Medical Aesthetic Drugs Product and Services
7.17.4 Sinclair Pharma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Sinclair Pharma Recent Developments/Updates
7.17.6 Sinclair Pharma Competitive Strengths & Weaknesses
7.18 Prollenium
7.18.1 Prollenium Details
7.18.2 Prollenium Major Business
7.18.3 Prollenium Medical Aesthetic Drugs Product and Services
7.18.4 Prollenium Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Prollenium Recent Developments/Updates
7.18.6 Prollenium Competitive Strengths & Weaknesses
7.19 Lumenis
7.19.1 Lumenis Details
7.19.2 Lumenis Major Business
7.19.3 Lumenis Medical Aesthetic Drugs Product and Services
7.19.4 Lumenis Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Lumenis Recent Developments/Updates
7.19.6 Lumenis Competitive Strengths & Weaknesses
7.20 Hologic
7.20.1 Hologic Details
7.20.2 Hologic Major Business
7.20.3 Hologic Medical Aesthetic Drugs Product and Services
7.20.4 Hologic Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Hologic Recent Developments/Updates
7.20.6 Hologic Competitive Strengths & Weaknesses
7.21 Bloomage Biotechnology Corporation Limited
7.21.1 Bloomage Biotechnology Corporation Limited Details
7.21.2 Bloomage Biotechnology Corporation Limited Major Business
7.21.3 Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Product and Services
7.21.4 Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Bloomage Biotechnology Corporation Limited Recent Developments/Updates
7.21.6 Bloomage Biotechnology Corporation Limited Competitive Strengths & Weaknesses
7.22 Shanghai Shyndec Pharmaceutical Co., Ltd.
7.22.1 Shanghai Shyndec Pharmaceutical Co., Ltd. Details
7.22.2 Shanghai Shyndec Pharmaceutical Co., Ltd. Major Business
7.22.3 Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Product and Services
7.22.4 Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Shanghai Shyndec Pharmaceutical Co., Ltd. Recent Developments/Updates
7.22.6 Shanghai Shyndec Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.23 Lancy Co., Ltd.
7.23.1 Lancy Co., Ltd. Details
7.23.2 Lancy Co., Ltd. Major Business
7.23.3 Lancy Co., Ltd. Medical Aesthetic Drugs Product and Services
7.23.4 Lancy Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Lancy Co., Ltd. Recent Developments/Updates
7.23.6 Lancy Co., Ltd. Competitive Strengths & Weaknesses
7.24 Aoyuan Beauty Valley Technology Co., Ltd.
7.24.1 Aoyuan Beauty Valley Technology Co., Ltd. Details
7.24.2 Aoyuan Beauty Valley Technology Co., Ltd. Major Business
7.24.3 Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Product and Services
7.24.4 Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Aoyuan Beauty Valley Technology Co., Ltd. Recent Developments/Updates
7.24.6 Aoyuan Beauty Valley Technology Co., Ltd. Competitive Strengths & Weaknesses
7.25 Huadong MEDICINE Co., Ltd.
7.25.1 Huadong MEDICINE Co., Ltd. Details
7.25.2 Huadong MEDICINE Co., Ltd. Major Business
7.25.3 Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Product and Services
7.25.4 Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Huadong MEDICINE Co., Ltd. Recent Developments/Updates
7.25.6 Huadong MEDICINE Co., Ltd. Competitive Strengths & Weaknesses
7.26 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
7.26.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Details
7.26.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Major Business
7.26.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Product and Services
7.26.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
7.26.6 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Competitive Strengths & Weaknesses
7.27 Lushang Freda Pharmaceutical Co., Ltd.
7.27.1 Lushang Freda Pharmaceutical Co., Ltd. Details
7.27.2 Lushang Freda Pharmaceutical Co., Ltd. Major Business
7.27.3 Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Product and Services
7.27.4 Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 Lushang Freda Pharmaceutical Co., Ltd. Recent Developments/Updates
7.27.6 Lushang Freda Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.28 Guangdong Marubi Biotechnology Co., Ltd.
7.28.1 Guangdong Marubi Biotechnology Co., Ltd. Details
7.28.2 Guangdong Marubi Biotechnology Co., Ltd. Major Business
7.28.3 Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Product and Services
7.28.4 Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 Guangdong Marubi Biotechnology Co., Ltd. Recent Developments/Updates
7.28.6 Guangdong Marubi Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.29 Shenzhen Lifotronic Technology Co., Ltd.
7.29.1 Shenzhen Lifotronic Technology Co., Ltd. Details
7.29.2 Shenzhen Lifotronic Technology Co., Ltd. Major Business
7.29.3 Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Product and Services
7.29.4 Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 Shenzhen Lifotronic Technology Co., Ltd. Recent Developments/Updates
7.29.6 Shenzhen Lifotronic Technology Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Medical Aesthetic Drugs Industry Chain
8.2 Medical Aesthetic Drugs Upstream Analysis
8.3 Medical Aesthetic Drugs Midstream Analysis
8.4 Medical Aesthetic Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Medical Aesthetic Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Medical Aesthetic Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Medical Aesthetic Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Medical Aesthetic Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Medical Aesthetic Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Medical Aesthetic Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Medical Aesthetic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Medical Aesthetic Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Medical Aesthetic Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Medical Aesthetic Drugs Players in 2022
Table 12. World Medical Aesthetic Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Medical Aesthetic Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Medical Aesthetic Drugs Player
Table 15. Medical Aesthetic Drugs Market: Company Product Type Footprint
Table 16. Medical Aesthetic Drugs Market: Company Product Application Footprint
Table 17. Medical Aesthetic Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Medical Aesthetic Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Medical Aesthetic Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Medical Aesthetic Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Medical Aesthetic Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Medical Aesthetic Drugs Revenue Market Share (2018-2023)
Table 23. China Based Medical Aesthetic Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Medical Aesthetic Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Medical Aesthetic Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Medical Aesthetic Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Medical Aesthetic Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Medical Aesthetic Drugs Revenue Market Share (2018-2023)
Table 29. World Medical Aesthetic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Medical Aesthetic Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Medical Aesthetic Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Medical Aesthetic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Medical Aesthetic Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Medical Aesthetic Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Allergan Basic Information, Area Served and Competitors
Table 36. Allergan Major Business
Table 37. Allergan Medical Aesthetic Drugs Product and Services
Table 38. Allergan Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Allergan Recent Developments/Updates
Table 40. Allergan Competitive Strengths & Weaknesses
Table 41. Galderma Basic Information, Area Served and Competitors
Table 42. Galderma Major Business
Table 43. Galderma Medical Aesthetic Drugs Product and Services
Table 44. Galderma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Galderma Recent Developments/Updates
Table 46. Galderma Competitive Strengths & Weaknesses
Table 47. LG Life Science Basic Information, Area Served and Competitors
Table 48. LG Life Science Major Business
Table 49. LG Life Science Medical Aesthetic Drugs Product and Services
Table 50. LG Life Science Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. LG Life Science Recent Developments/Updates
Table 52. LG Life Science Competitive Strengths & Weaknesses
Table 53. Merz Aesthetics Basic Information, Area Served and Competitors
Table 54. Merz Aesthetics Major Business
Table 55. Merz Aesthetics Medical Aesthetic Drugs Product and Services
Table 56. Merz Aesthetics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Merz Aesthetics Recent Developments/Updates
Table 58. Merz Aesthetics Competitive Strengths & Weaknesses
Table 59. Ipsen Basic Information, Area Served and Competitors
Table 60. Ipsen Major Business
Table 61. Ipsen Medical Aesthetic Drugs Product and Services
Table 62. Ipsen Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Ipsen Recent Developments/Updates
Table 64. Ipsen Competitive Strengths & Weaknesses
Table 65. Syneron Medical Basic Information, Area Served and Competitors
Table 66. Syneron Medical Major Business
Table 67. Syneron Medical Medical Aesthetic Drugs Product and Services
Table 68. Syneron Medical Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Syneron Medical Recent Developments/Updates
Table 70. Syneron Medical Competitive Strengths & Weaknesses
Table 71. Cynosure Basic Information, Area Served and Competitors
Table 72. Cynosure Major Business
Table 73. Cynosure Medical Aesthetic Drugs Product and Services
Table 74. Cynosure Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Cynosure Recent Developments/Updates
Table 76. Cynosure Competitive Strengths & Weaknesses
Table 77. Mentor Worldwide Basic Information, Area Served and Competitors
Table 78. Mentor Worldwide Major Business
Table 79. Mentor Worldwide Medical Aesthetic Drugs Product and Services
Table 80. Mentor Worldwide Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Mentor Worldwide Recent Developments/Updates
Table 82. Mentor Worldwide Competitive Strengths & Weaknesses
Table 83. Medytox Basic Information, Area Served and Competitors
Table 84. Medytox Major Business
Table 85. Medytox Medical Aesthetic Drugs Product and Services
Table 86. Medytox Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Medytox Recent Developments/Updates
Table 88. Medytox Competitive Strengths & Weaknesses
Table 89. Valeant Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Valeant Pharmaceuticals Major Business
Table 91. Valeant Pharmaceuticals Medical Aesthetic Drugs Product and Services
Table 92. Valeant Pharmaceuticals Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Valeant Pharmaceuticals Recent Developments/Updates
Table 94. Valeant Pharmaceuticals Competitive Strengths & Weaknesses
Table 95. Fosun Pharma Basic Information, Area Served and Competitors
Table 96. Fosun Pharma Major Business
Table 97. Fosun Pharma Medical Aesthetic Drugs Product and Services
Table 98. Fosun Pharma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Fosun Pharma Recent Developments/Updates
Table 100. Fosun Pharma Competitive Strengths & Weaknesses
Table 101. Teoxane Basic Information, Area Served and Competitors
Table 102. Teoxane Major Business
Table 103. Teoxane Medical Aesthetic Drugs Product and Services
Table 104. Teoxane Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Teoxane Recent Developments/Updates
Table 106. Teoxane Competitive Strengths & Weaknesses
Table 107. Bloomage Basic Information, Area Served and Competitors
Table 108. Bloomage Major Business
Table 109. Bloomage Medical Aesthetic Drugs Product and Services
Table 110. Bloomage Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Bloomage Recent Developments/Updates
Table 112. Bloomage Competitive Strengths & Weaknesses
Table 113. GC Aesthetics Basic Information, Area Served and Competitors
Table 114. GC Aesthetics Major Business
Table 115. GC Aesthetics Medical Aesthetic Drugs Product and Services
Table 116. GC Aesthetics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. GC Aesthetics Recent Developments/Updates
Table 118. GC Aesthetics Competitive Strengths & Weaknesses
Table 119. Suneva Medical Basic Information, Area Served and Competitors
Table 120. Suneva Medical Major Business
Table 121. Suneva Medical Medical Aesthetic Drugs Product and Services
Table 122. Suneva Medical Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Suneva Medical Recent Developments/Updates
Table 124. Suneva Medical Competitive Strengths & Weaknesses
Table 125. Revance Therapeutics Basic Information, Area Served and Competitors
Table 126. Revance Therapeutics Major Business
Table 127. Revance Therapeutics Medical Aesthetic Drugs Product and Services
Table 128. Revance Therapeutics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Revance Therapeutics Recent Developments/Updates
Table 130. Revance Therapeutics Competitive Strengths & Weaknesses
Table 131. Sinclair Pharma Basic Information, Area Served and Competitors
Table 132. Sinclair Pharma Major Business
Table 133. Sinclair Pharma Medical Aesthetic Drugs Product and Services
Table 134. Sinclair Pharma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Sinclair Pharma Recent Developments/Updates
Table 136. Sinclair Pharma Competitive Strengths & Weaknesses
Table 137. Prollenium Basic Information, Area Served and Competitors
Table 138. Prollenium Major Business
Table 139. Prollenium Medical Aesthetic Drugs Product and Services
Table 140. Prollenium Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Prollenium Recent Developments/Updates
Table 142. Prollenium Competitive Strengths & Weaknesses
Table 143. Lumenis Basic Information, Area Served and Competitors
Table 144. Lumenis Major Business
Table 145. Lumenis Medical Aesthetic Drugs Product and Services
Table 146. Lumenis Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Lumenis Recent Developments/Updates
Table 148. Lumenis Competitive Strengths & Weaknesses
Table 149. Hologic Basic Information, Area Served and Competitors
Table 150. Hologic Major Business
Table 151. Hologic Medical Aesthetic Drugs Product and Services
Table 152. Hologic Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Hologic Recent Developments/Updates
Table 154. Hologic Competitive Strengths & Weaknesses
Table 155. Bloomage Biotechnology Corporation Limited Basic Information, Area Served and Competitors
Table 156. Bloomage Biotechnology Corporation Limited Major Business
Table 157. Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Product and Services
Table 158. Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Bloomage Biotechnology Corporation Limited Recent Developments/Updates
Table 160. Bloomage Biotechnology Corporation Limited Competitive Strengths & Weaknesses
Table 161. Shanghai Shyndec Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 162. Shanghai Shyndec Pharmaceutical Co., Ltd. Major Business
Table 163. Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 164. Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Shanghai Shyndec Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 166. Shanghai Shyndec Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 167. Lancy Co., Ltd. Basic Information, Area Served and Competitors
Table 168. Lancy Co., Ltd. Major Business
Table 169. Lancy Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 170. Lancy Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Lancy Co., Ltd. Recent Developments/Updates
Table 172. Lancy Co., Ltd. Competitive Strengths & Weaknesses
Table 173. Aoyuan Beauty Valley Technology Co., Ltd. Basic Information, Area Served and Competitors
Table 174. Aoyuan Beauty Valley Technology Co., Ltd. Major Business
Table 175. Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 176. Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Aoyuan Beauty Valley Technology Co., Ltd. Recent Developments/Updates
Table 178. Aoyuan Beauty Valley Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 179. Huadong MEDICINE Co., Ltd. Basic Information, Area Served and Competitors
Table 180. Huadong MEDICINE Co., Ltd. Major Business
Table 181. Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 182. Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. Huadong MEDICINE Co., Ltd. Recent Developments/Updates
Table 184. Huadong MEDICINE Co., Ltd. Competitive Strengths & Weaknesses
Table 185. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Basic Information, Area Served and Competitors
Table 186. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Major Business
Table 187. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 188. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 190. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Competitive Strengths & Weaknesses
Table 191. Lushang Freda Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 192. Lushang Freda Pharmaceutical Co., Ltd. Major Business
Table 193. Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 194. Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. Lushang Freda Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 196. Lushang Freda Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 197. Guangdong Marubi Biotechnology Co., Ltd. Basic Information, Area Served and Competitors
Table 198. Guangdong Marubi Biotechnology Co., Ltd. Major Business
Table 199. Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 200. Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. Guangdong Marubi Biotechnology Co., Ltd. Recent Developments/Updates
Table 202. Shenzhen Lifotronic Technology Co., Ltd. Basic Information, Area Served and Competitors
Table 203. Shenzhen Lifotronic Technology Co., Ltd.Major Business
Table 204. Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 205. Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 206. Global Key Players of Medical Aesthetic Drugs Upstream (Raw Materials)
Table 207. Medical Aesthetic Drugs Typical Customers
List of Figure
Figure 1. Medical Aesthetic Drugs Picture
Figure 2. World Medical Aesthetic Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Medical Aesthetic Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Medical Aesthetic Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Medical Aesthetic Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Medical Aesthetic Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Medical Aesthetic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Medical Aesthetic Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Aesthetic Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Aesthetic Drugs Markets in 2022
Figure 27. United States VS China: Medical Aesthetic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Medical Aesthetic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Medical Aesthetic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Medical Aesthetic Drugs Market Size Market Share by Type in 2022
Figure 31. Dermal Fillers
Figure 32. Botulinum Toxin
Figure 33. Breast Implants
Figure 34. Others
Figure 35. World Medical Aesthetic Drugs Market Size Market Share by Type (2018-2029)
Figure 36. World Medical Aesthetic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Medical Aesthetic Drugs Market Size Market Share by Application in 2022
Figure 38. Facial Injectable
Figure 39. Fat Reduction
Figure 40. Breast Implant
Figure 41. Others
Figure 42. Medical Aesthetic Drugs Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Table 1. World Medical Aesthetic Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Medical Aesthetic Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Medical Aesthetic Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Medical Aesthetic Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Medical Aesthetic Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Medical Aesthetic Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Medical Aesthetic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Medical Aesthetic Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Medical Aesthetic Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Medical Aesthetic Drugs Players in 2022
Table 12. World Medical Aesthetic Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Medical Aesthetic Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Medical Aesthetic Drugs Player
Table 15. Medical Aesthetic Drugs Market: Company Product Type Footprint
Table 16. Medical Aesthetic Drugs Market: Company Product Application Footprint
Table 17. Medical Aesthetic Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Medical Aesthetic Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Medical Aesthetic Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Medical Aesthetic Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Medical Aesthetic Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Medical Aesthetic Drugs Revenue Market Share (2018-2023)
Table 23. China Based Medical Aesthetic Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Medical Aesthetic Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Medical Aesthetic Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Medical Aesthetic Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Medical Aesthetic Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Medical Aesthetic Drugs Revenue Market Share (2018-2023)
Table 29. World Medical Aesthetic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Medical Aesthetic Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Medical Aesthetic Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Medical Aesthetic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Medical Aesthetic Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Medical Aesthetic Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Allergan Basic Information, Area Served and Competitors
Table 36. Allergan Major Business
Table 37. Allergan Medical Aesthetic Drugs Product and Services
Table 38. Allergan Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Allergan Recent Developments/Updates
Table 40. Allergan Competitive Strengths & Weaknesses
Table 41. Galderma Basic Information, Area Served and Competitors
Table 42. Galderma Major Business
Table 43. Galderma Medical Aesthetic Drugs Product and Services
Table 44. Galderma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Galderma Recent Developments/Updates
Table 46. Galderma Competitive Strengths & Weaknesses
Table 47. LG Life Science Basic Information, Area Served and Competitors
Table 48. LG Life Science Major Business
Table 49. LG Life Science Medical Aesthetic Drugs Product and Services
Table 50. LG Life Science Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. LG Life Science Recent Developments/Updates
Table 52. LG Life Science Competitive Strengths & Weaknesses
Table 53. Merz Aesthetics Basic Information, Area Served and Competitors
Table 54. Merz Aesthetics Major Business
Table 55. Merz Aesthetics Medical Aesthetic Drugs Product and Services
Table 56. Merz Aesthetics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Merz Aesthetics Recent Developments/Updates
Table 58. Merz Aesthetics Competitive Strengths & Weaknesses
Table 59. Ipsen Basic Information, Area Served and Competitors
Table 60. Ipsen Major Business
Table 61. Ipsen Medical Aesthetic Drugs Product and Services
Table 62. Ipsen Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Ipsen Recent Developments/Updates
Table 64. Ipsen Competitive Strengths & Weaknesses
Table 65. Syneron Medical Basic Information, Area Served and Competitors
Table 66. Syneron Medical Major Business
Table 67. Syneron Medical Medical Aesthetic Drugs Product and Services
Table 68. Syneron Medical Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Syneron Medical Recent Developments/Updates
Table 70. Syneron Medical Competitive Strengths & Weaknesses
Table 71. Cynosure Basic Information, Area Served and Competitors
Table 72. Cynosure Major Business
Table 73. Cynosure Medical Aesthetic Drugs Product and Services
Table 74. Cynosure Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Cynosure Recent Developments/Updates
Table 76. Cynosure Competitive Strengths & Weaknesses
Table 77. Mentor Worldwide Basic Information, Area Served and Competitors
Table 78. Mentor Worldwide Major Business
Table 79. Mentor Worldwide Medical Aesthetic Drugs Product and Services
Table 80. Mentor Worldwide Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Mentor Worldwide Recent Developments/Updates
Table 82. Mentor Worldwide Competitive Strengths & Weaknesses
Table 83. Medytox Basic Information, Area Served and Competitors
Table 84. Medytox Major Business
Table 85. Medytox Medical Aesthetic Drugs Product and Services
Table 86. Medytox Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Medytox Recent Developments/Updates
Table 88. Medytox Competitive Strengths & Weaknesses
Table 89. Valeant Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Valeant Pharmaceuticals Major Business
Table 91. Valeant Pharmaceuticals Medical Aesthetic Drugs Product and Services
Table 92. Valeant Pharmaceuticals Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Valeant Pharmaceuticals Recent Developments/Updates
Table 94. Valeant Pharmaceuticals Competitive Strengths & Weaknesses
Table 95. Fosun Pharma Basic Information, Area Served and Competitors
Table 96. Fosun Pharma Major Business
Table 97. Fosun Pharma Medical Aesthetic Drugs Product and Services
Table 98. Fosun Pharma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Fosun Pharma Recent Developments/Updates
Table 100. Fosun Pharma Competitive Strengths & Weaknesses
Table 101. Teoxane Basic Information, Area Served and Competitors
Table 102. Teoxane Major Business
Table 103. Teoxane Medical Aesthetic Drugs Product and Services
Table 104. Teoxane Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Teoxane Recent Developments/Updates
Table 106. Teoxane Competitive Strengths & Weaknesses
Table 107. Bloomage Basic Information, Area Served and Competitors
Table 108. Bloomage Major Business
Table 109. Bloomage Medical Aesthetic Drugs Product and Services
Table 110. Bloomage Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Bloomage Recent Developments/Updates
Table 112. Bloomage Competitive Strengths & Weaknesses
Table 113. GC Aesthetics Basic Information, Area Served and Competitors
Table 114. GC Aesthetics Major Business
Table 115. GC Aesthetics Medical Aesthetic Drugs Product and Services
Table 116. GC Aesthetics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. GC Aesthetics Recent Developments/Updates
Table 118. GC Aesthetics Competitive Strengths & Weaknesses
Table 119. Suneva Medical Basic Information, Area Served and Competitors
Table 120. Suneva Medical Major Business
Table 121. Suneva Medical Medical Aesthetic Drugs Product and Services
Table 122. Suneva Medical Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Suneva Medical Recent Developments/Updates
Table 124. Suneva Medical Competitive Strengths & Weaknesses
Table 125. Revance Therapeutics Basic Information, Area Served and Competitors
Table 126. Revance Therapeutics Major Business
Table 127. Revance Therapeutics Medical Aesthetic Drugs Product and Services
Table 128. Revance Therapeutics Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Revance Therapeutics Recent Developments/Updates
Table 130. Revance Therapeutics Competitive Strengths & Weaknesses
Table 131. Sinclair Pharma Basic Information, Area Served and Competitors
Table 132. Sinclair Pharma Major Business
Table 133. Sinclair Pharma Medical Aesthetic Drugs Product and Services
Table 134. Sinclair Pharma Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Sinclair Pharma Recent Developments/Updates
Table 136. Sinclair Pharma Competitive Strengths & Weaknesses
Table 137. Prollenium Basic Information, Area Served and Competitors
Table 138. Prollenium Major Business
Table 139. Prollenium Medical Aesthetic Drugs Product and Services
Table 140. Prollenium Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Prollenium Recent Developments/Updates
Table 142. Prollenium Competitive Strengths & Weaknesses
Table 143. Lumenis Basic Information, Area Served and Competitors
Table 144. Lumenis Major Business
Table 145. Lumenis Medical Aesthetic Drugs Product and Services
Table 146. Lumenis Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Lumenis Recent Developments/Updates
Table 148. Lumenis Competitive Strengths & Weaknesses
Table 149. Hologic Basic Information, Area Served and Competitors
Table 150. Hologic Major Business
Table 151. Hologic Medical Aesthetic Drugs Product and Services
Table 152. Hologic Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Hologic Recent Developments/Updates
Table 154. Hologic Competitive Strengths & Weaknesses
Table 155. Bloomage Biotechnology Corporation Limited Basic Information, Area Served and Competitors
Table 156. Bloomage Biotechnology Corporation Limited Major Business
Table 157. Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Product and Services
Table 158. Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Bloomage Biotechnology Corporation Limited Recent Developments/Updates
Table 160. Bloomage Biotechnology Corporation Limited Competitive Strengths & Weaknesses
Table 161. Shanghai Shyndec Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 162. Shanghai Shyndec Pharmaceutical Co., Ltd. Major Business
Table 163. Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 164. Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Shanghai Shyndec Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 166. Shanghai Shyndec Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 167. Lancy Co., Ltd. Basic Information, Area Served and Competitors
Table 168. Lancy Co., Ltd. Major Business
Table 169. Lancy Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 170. Lancy Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Lancy Co., Ltd. Recent Developments/Updates
Table 172. Lancy Co., Ltd. Competitive Strengths & Weaknesses
Table 173. Aoyuan Beauty Valley Technology Co., Ltd. Basic Information, Area Served and Competitors
Table 174. Aoyuan Beauty Valley Technology Co., Ltd. Major Business
Table 175. Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 176. Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Aoyuan Beauty Valley Technology Co., Ltd. Recent Developments/Updates
Table 178. Aoyuan Beauty Valley Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 179. Huadong MEDICINE Co., Ltd. Basic Information, Area Served and Competitors
Table 180. Huadong MEDICINE Co., Ltd. Major Business
Table 181. Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 182. Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. Huadong MEDICINE Co., Ltd. Recent Developments/Updates
Table 184. Huadong MEDICINE Co., Ltd. Competitive Strengths & Weaknesses
Table 185. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Basic Information, Area Served and Competitors
Table 186. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Major Business
Table 187. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 188. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 190. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Competitive Strengths & Weaknesses
Table 191. Lushang Freda Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 192. Lushang Freda Pharmaceutical Co., Ltd. Major Business
Table 193. Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 194. Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. Lushang Freda Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 196. Lushang Freda Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 197. Guangdong Marubi Biotechnology Co., Ltd. Basic Information, Area Served and Competitors
Table 198. Guangdong Marubi Biotechnology Co., Ltd. Major Business
Table 199. Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 200. Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. Guangdong Marubi Biotechnology Co., Ltd. Recent Developments/Updates
Table 202. Shenzhen Lifotronic Technology Co., Ltd. Basic Information, Area Served and Competitors
Table 203. Shenzhen Lifotronic Technology Co., Ltd.Major Business
Table 204. Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Product and Services
Table 205. Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 206. Global Key Players of Medical Aesthetic Drugs Upstream (Raw Materials)
Table 207. Medical Aesthetic Drugs Typical Customers
List of Figure
Figure 1. Medical Aesthetic Drugs Picture
Figure 2. World Medical Aesthetic Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Medical Aesthetic Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Medical Aesthetic Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Medical Aesthetic Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Medical Aesthetic Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Medical Aesthetic Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Medical Aesthetic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Medical Aesthetic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Medical Aesthetic Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Aesthetic Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Aesthetic Drugs Markets in 2022
Figure 27. United States VS China: Medical Aesthetic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Medical Aesthetic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Medical Aesthetic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Medical Aesthetic Drugs Market Size Market Share by Type in 2022
Figure 31. Dermal Fillers
Figure 32. Botulinum Toxin
Figure 33. Breast Implants
Figure 34. Others
Figure 35. World Medical Aesthetic Drugs Market Size Market Share by Type (2018-2029)
Figure 36. World Medical Aesthetic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Medical Aesthetic Drugs Market Size Market Share by Application in 2022
Figure 38. Facial Injectable
Figure 39. Fat Reduction
Figure 40. Breast Implant
Figure 41. Others
Figure 42. Medical Aesthetic Drugs Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
